Skip to main content
Log in

Intra-articular hyaluronic acid increases cartilage breakdown biomarker in patients with knee osteoarthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Intra-articular hyaluronic acid has been used in treatment of patients with knee osteoarthritis. Though its effect on pain has been well studied, it is not clear how it affects the articular cartilage. This is a preliminary study to evaluate the kinetics of urinary collagen type-II C-telopeptide (CTX-II) as a biomarker of collagen breakdown in response to intra-articular hyaluronic acid injection in patients with symptomatic knee osteoarthritis. Intra-articular injections of hyaluronan were administered to ten patients with symptomatic knee osteoarthritis. Urine collection for urinary CTX-II was obtained at baseline, before each injection and once every other week for a total of 6 months. Urine CTX-II was measured using a CartiLaps© ELISA kit. There was a statistically significant increase (p = 0.0136) in CTX-II a week after the third intra-articular injection of hyaluronic acid (6,216 ng/mmol ± 4,428) compared with baseline (2,233 ng/mmol ± 1,220). This increase in CTX-II was sustained throughout the entire 6 months follow-up period (repeated measures ANOVA, p < 0.015). This is the first study of changes in an osteoarthritis biomarker after intra-articular hyaluronic acid injections in patients with symptomatic knee osteoarthritis. Contrary to our initial hypothesis that CTX-II levels should decrease after intra-articular hyaluronic acid injections, we found a significant increase in urinary CTX-II levels that was sustained throughout the study. These observations suggest that intra-articular hyaluronic acid injections may accelerate cartilage breakdown in patients with symptomatic knee osteoarthritis. The responsible mechanisms are unknown and warrant further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

CTX-II:

Collagen type-II C-telopeptide

OA:

Osteoarthritis

HA:

Hyaluronic acid

RA:

Rheumatoid arthritis

HMW:

High molecular weight

References

  1. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF (1987) The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 30(8):914–918

    Article  CAS  PubMed  Google Scholar 

  2. National Center for Chronic Disease Prevention and Health Promotion (2008) http://www.cdc.gov/arthritis/arthritis/osteoarthritis.htm. Last revised: January 11

  3. Supartz package insert. In: Smith and Nephew, Memphis; Revised: January 30 2007

  4. Brzusek D, Petron D (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 24(12):3307–3322

    Article  CAS  PubMed  Google Scholar 

  5. Caborn D, Rush J, Lanzer W, Parenti D, Murray C (2004) A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 31(2):333–343

    CAS  PubMed  Google Scholar 

  6. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D et al (2001) Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. Arthritis Rheum 44(8):1800–1807

    Article  CAS  PubMed  Google Scholar 

  7. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E et al (2001) Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29(3):209–215

    Article  CAS  PubMed  Google Scholar 

  8. Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46(10):2613–2624

    Article  CAS  PubMed  Google Scholar 

  9. Garnero P, Conrozier T, Christgau S, Mathieu P, Delmas PD, Vignon E (2003) Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 62(10):939–943

    Article  CAS  PubMed  Google Scholar 

  10. Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau S, Christiansen C et al (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 50(8):2471–2478

    Article  CAS  PubMed  Google Scholar 

  11. Jordan KM, Syddall HE, Garnero P, Gineyts E, Dennison EM, Sayer AA et al (2006) Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65(7):871–877

    Article  CAS  PubMed  Google Scholar 

  12. Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ, Garnero P (2006) Hellio Le Graverand MP, et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann Rheum Dis 65(3):360–365

    Article  CAS  PubMed  Google Scholar 

  13. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H et al (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65(8):1050–1054

    Article  CAS  PubMed  Google Scholar 

  14. Garnero P, Peterfy C, Zaim S, Schoenharting M (2005) Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study. Arthritis Rheum 52(9):2822–2829

    Article  CAS  PubMed  Google Scholar 

  15. Bedson J, Croft PR (2008) The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature. BMC Musculoskelet Disord 9:116

    Article  PubMed  Google Scholar 

  16. Zhai G, Cicuttini F, Ding C, Scott F, Garnero P, Jones G (2007) Correlates of knee pain in younger subjects. Clin Rheumatol 26(1):75–80

    Article  PubMed  Google Scholar 

  17. Gineyts E, Mo JA, Ko A, Henriksen DB, Curtis SP, Gertz BJ et al (2004) Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis. Ann Rheum Dis 63(7):857–861

    Article  CAS  PubMed  Google Scholar 

  18. Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB (2006) Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum 54(8):2496–2504

    Article  CAS  PubMed  Google Scholar 

  19. Qvist P, Munk M, Hoyle N, Christiansen C (2004) Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years. Clin Chim Acta 350(1–2):167–173

    Article  CAS  PubMed  Google Scholar 

  20. Pozo MA, Balazs EA, Belmonte C (1997) Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 116(1):3–9

    Article  CAS  PubMed  Google Scholar 

  21. Gomis A, Miralles A, Schmidt RF, Belmonte C (2007) Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application. Pain 130(1–2):126–136

    Article  CAS  PubMed  Google Scholar 

  22. Gomis A, Miralles A, Schmidt RF, Belmonte C (2009) Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig. Osteoarthritis Cartilage 17(6):798–804

    Article  CAS  PubMed  Google Scholar 

  23. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB (2000) Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum 43(5):1165–1174

    Article  CAS  PubMed  Google Scholar 

  24. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P et al (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165(4):1863–1870

    CAS  PubMed  Google Scholar 

  25. Fernandes JC, Martel-Pelletier J, Pelletier JP (2002) The role of cytokines in osteoarthritis pathophysiology. Biorheology 39(1–2):237–246

    CAS  PubMed  Google Scholar 

  26. Lohmander LS, Atley LM, Pietka TA, Eyre DR (2003) The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 48(11):3130–3139

    Article  CAS  PubMed  Google Scholar 

  27. Nielsen RH, Stoop R, Leeming DJ, Stolina M, Qvist P, Christiansen C et al (2008) Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis. Biomarkers 13(1):79–87

    Article  CAS  PubMed  Google Scholar 

  28. Kim HJ, Lee YH, Kim CK (2009) Changes in serum cartilage oligomeric matrix protein (COMP), plasma CPK and plasma hs-CRP in relation to running distance in a marathon (42.195 km) and an ultra-marathon (200 km) race. Eur J Appl Physiol 105(5):765–770

    Article  CAS  PubMed  Google Scholar 

  29. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60(6):619–626

    Article  CAS  PubMed  Google Scholar 

  30. Depuy Website: http://www.orthoviscline.com/replace-what-missing/safety

  31. Bagger YZ, Tanko LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L et al (2005) Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone 37(3):425–430

    Article  CAS  PubMed  Google Scholar 

  32. Manicourt DH, Azria M, Mindeholm L, Thonar EJ, Devogelaer JP (2006) Oral salmon calcitonin reduces Lequesne’s algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 54(10):3205–3211

    Article  CAS  PubMed  Google Scholar 

  33. Manicourt DH, Bevilacqua M, Righini V, Famaey JP, Devogelaer JP (2005) Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D 6(5):261–271

    Article  CAS  PubMed  Google Scholar 

  34. Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C (2002) Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 61(6):530–533

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Reetakshi Arora, PhD

John I. Thornby, PhD

Conflicts of interest statement

None of the authors involve have any financial and personal relationships with other people or organizations that could inappropriately influence the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernard Ng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzalez-Fuentes, A.M., Green, D.M., Rossen, R.D. et al. Intra-articular hyaluronic acid increases cartilage breakdown biomarker in patients with knee osteoarthritis. Clin Rheumatol 29, 619–624 (2010). https://doi.org/10.1007/s10067-010-1376-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1376-8

Keywords

Navigation